Australia - Inggeris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

thebe international - piperonyl butoxide | bioallethrin - household insecticide - boat | caravan | domestic and/or public area | patio | balcony | deck | holiday van | landing | porch | propellers | running gea - mosquito | adult mosquitoes

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - ezetimibe 10mg; simvastatin 10mg - tablet - 10/10mg - active: ezetimibe 10mg simvastatin 10mg excipient: butylated hydroxyanisole citric acid monohydrate croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose propyl gallate - homozygous familial hypercholesterolaemia vytorin is indicated for the reduction of elevated total-c and ldl-c levels in adult and adolescent (10 to 17 years of age) patients with hofh. patients may also receive adjunctive treatments (e.g., ldl apheresis).

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - ezetimibe 10mg; simvastatin 20mg - tablet - 10/20mg - active: ezetimibe 10mg simvastatin 20mg excipient: butylated hydroxyanisole citric acid monohydrate croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose propyl gallate - homozygous familial hypercholesterolaemia vytorin is indicated for the reduction of elevated total-c and ldl-c levels in adult and adolescent (10 to 17 years of age) patients with hofh. patients may also receive adjunctive treatments (e.g., ldl apheresis).

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - ezetimibe 10mg; simvastatin 40mg - tablet - 10/40mg - active: ezetimibe 10mg simvastatin 40mg excipient: butylated hydroxyanisole citric acid monohydrate croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose propyl gallate - homozygous familial hypercholesterolaemia vytorin is indicated for the reduction of elevated total-c and ldl-c levels in adult and adolescent (10 to 17 years of age) patients with hofh. patients may also receive adjunctive treatments (e.g., ldl apheresis).

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - ezetimibe 10mg; simvastatin 80mg - tablet - 10/80mg - active: ezetimibe 10mg simvastatin 80mg excipient: butylated hydroxyanisole citric acid monohydrate croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose propyl gallate - homozygous familial hypercholesterolaemia vytorin is indicated for the reduction of elevated total-c and ldl-c levels in adult and adolescent (10 to 17 years of age) patients with hofh. patients may also receive adjunctive treatments (e.g., ldl apheresis).

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - tibolone -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - tibolone -

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - tibolone 2.5mg;   - tablet - 2.5 mg - active: tibolone 2.5mg   excipient: ascorbyl palmitate lactose monohydrate magnesium stearate potato starch - · treatment of symptoms resulting from the natural or surgical menopause in post-menopausal women. women above 60 years of age should only start with livial treatment when they are intolerant of or contraindicated for other medicinal products approved for the treatment of oestrogen deficiency symptoms. · prevention of bone mineral density loss in postmenopausal women at high risk of future osteoporotic fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of bone mineral density loss.

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - nafarelin - nasal spray, solution - 200 mcg/dose - gonadotropin-releasing hormones; nafarelin

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

actor pharmaceuticals pty ltd - tibolone, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; ascorbyl palmitate; magnesium stearate; potato starch - indications ? short-term treatment of symptoms resulting from the natural or surgical menopause in postmenopausal women.,? second line therapy for the prevention of bone mineral density loss in postmenopausal women at high risk of future osteoporotic fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of bone mineral density loss.,after careful selection of users, tibogen should be prescribed for the shortest duration consistent with treatment goals. review the need for continuation of treatment after 6 months, taking into account the risk-benefit ratio for the individual user at the moment (including cardiovascular disease and breast cancer, refer clinical trials and precautions). tibogen should only be continued for as long as the benefit outweighs the risks.